BCRX · Biocryst Pharmaceuticals Inc · Documents
$7.75
-0.19 (-2.39%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.99B
Shares
255.54M
Volume · Oct 21
5.03M
Avg daily vol (3M)
4.34M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-09-30 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-08-05 | — | |
| 8-K | — | 2024-06-13 | 2024-06-12 | |
| 10-Q | — | 2024-05-07 | 2024-03-31 | |
| 8-K | — | 2024-05-06 | — | |
| DEF 14A | — | 2024-04-25 | 2024-06-12 | |
| 10-K | — | 2024-02-27 | 2023-12-31 | |
| 8-K | — | 2024-02-26 | — | |
| 8-K | — | 2024-01-18 | 2024-01-16 | |
| 8-K | — | 2024-01-08 | 2024-01-05 | |
| 8-K | — | 2023-12-01 | 2023-11-28 | |
| 8-K | — | 2023-11-30 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-03 | — | |
| 8-K | — | 2023-11-03 | — | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-26 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-07-11 | 2023-07-07 | |
| 8-K | — | 2023-06-14 | 2023-06-13 | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| 8-K | — | 2023-05-03 | — | |
| DEF 14A | — | 2023-04-27 | — | |
| 8-K | — | 2023-04-18 | 2023-04-17 | |
| 8-K | — | 2023-03-13 | — | |
| 10-K | — | 2023-02-27 | 2022-12-31 | |
| 8-K | — | 2023-02-21 | — | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-15 | — | |
| 10-Q | — | 2022-11-04 | 2022-09-30 | |
| 8-K | — | 2022-11-01 | — | |
| 8-K | — | 2022-09-14 | 2022-09-09 | |
| 8-K | — | 2022-08-25 | — | |
| 10-Q | — | 2022-08-05 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-06-07 | — | |
| 10-Q | — | 2022-05-09 | 2022-03-31 | |
| 8-K | — | 2022-05-05 | — | |
| DEF 14A | — | 2022-04-25 | 2022-06-07 | |
| 8-K | — | 2022-04-11 | 2022-04-08 | |
| 8-K | — | 2022-04-08 | — | |
| 10-K | — | 2022-02-28 | 2021-12-31 | |
| 8-K | — | 2022-02-23 | — | |
| 8-K | — | 2022-02-22 | — | |
| 8-K | — | 2022-02-17 | — | |
| 8-K | — | 2022-02-08 | 2022-02-04 | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2022-01-07 | — |
Showing 51–100 of 161 filings
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
26 filings
25 filers
Visit website
Investor relations